Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
Necchi A, Madison R, Raggi D, Jacob JM, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Huang R, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Alexander BM, Grivas P, Ross JS. Necchi A, et al. Among authors: schrock ab. Eur Urol. 2020 Apr;77(4):548-556. doi: 10.1016/j.eururo.2020.01.003. Epub 2020 Jan 17. Eur Urol. 2020. PMID: 31959546
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors.
Schrock AB, Madison R, Rosenzweig M, Allen JM, Erlich RL, Wang SY, Chidiac T, Reddy VS, Riess JW, Yassa AE, Shakir A, Miller VA, Alexander BM, Venstrom J, McGregor K, Ali SM. Schrock AB, et al. Lung Cancer (Auckl). 2020 Apr 17;11:33-39. doi: 10.2147/LCTT.S239675. eCollection 2020. Lung Cancer (Auckl). 2020. PMID: 32368168 Free PMC article.
Evidence-Based Development and Clinical Use of Precision Oncology Therapeutics.
Comment LA, Ward AF, Schrock AB, Fabrizio D, Venstrom JM, Hegde PS, Alexander BM. Comment LA, et al. Among authors: schrock ab. Clin Pharmacol Ther. 2020 Sep;108(3):440-443. doi: 10.1002/cpt.1967. Epub 2020 Aug 3. Clin Pharmacol Ther. 2020. PMID: 32744335 Free PMC article. No abstract available.
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling.
Madison R, Schrock AB, Castellanos E, Gregg JP, Snider J, Ali SM, Miller VA, Singal G, Alexander BM, Venstrom JM, Chung JH. Madison R, et al. Among authors: schrock ab. Lung Cancer. 2020 Oct;148:69-78. doi: 10.1016/j.lungcan.2020.07.033. Epub 2020 Aug 6. Lung Cancer. 2020. PMID: 32823229 Free article.
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas.
Jacob J, Necchi A, Grivas P, Hughes M, Sanford T, Mollapour M, Shapiro O, Talal A, Sokol E, Vergilio JA, Killian J, Lin D, Williams E, Tse J, Ramkissoon S, Severson E, Hemmerich A, Ferguson N, Edgerly C, Duncan D, Huang R, Chung J, Madison R, Alexander B, Venstrom J, Reddy P, McGregor K, Elvin J, Schrock A, Danziger N, Pavlick D, Ross J, Bratslavsky G. Jacob J, et al. Urol Oncol. 2021 Oct;39(10):731.e1-731.e15. doi: 10.1016/j.urolonc.2020.12.021. Epub 2021 Jun 30. Urol Oncol. 2021. PMID: 34215504
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
Necchi A, Cucchiara V, Grivas P, Bratslavsky G, Jacob J, Spiess PE, Sokol ES, Killian JK, Lin D, Ramkissoon S, Huang RSP, Madison RW, Venstrom JM, Schrock AB, Danziger N, Decker B, Gjoerup O, Graf RP, Oxnard GR, Tukachinsky H, Ross JS. Necchi A, et al. Among authors: schrock ab. Cancer. 2021 Dec 15;127(24):4557-4564. doi: 10.1002/cncr.33865. Epub 2021 Aug 11. Cancer. 2021. PMID: 34379803 Free article.
166 results